fluocinonide has been researched along with Atrophy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lebwohl, M; Soung, J; Uliasz, A; Wong, V; Zeichner, J | 1 |
| Gans, EH; Kligman, AM; Sadiq, I; Stoudemayer, M; Stoudemayer, T | 1 |
| Hernández, J; Rivera, A; Sánchez, JL | 1 |
| Bielan, B | 1 |
| Chalker, DK; Smith, JG; Wehr, RF | 1 |
| Deffer, TA; Goette, DK | 1 |
2 trial(s) available for fluocinonide and Atrophy
| Article | Year |
|---|---|
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses.
Topics: Administration, Cutaneous; Adult; Atrophy; Clobetasol; Double-Blind Method; Drug Administration Schedule; Epidermis; Fluocinonide; Glucocorticoids; Humans; Skin Diseases | 2008 |
In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
Topics: Administration, Cutaneous; Adult; Atrophy; Clobetasol; Dose-Response Relationship, Drug; Emollients; Erythema; Female; Fluocinonide; Glucocorticoids; Humans; Middle Aged; Severity of Illness Index; Skin; Skin Diseases; Telangiectasis; Water Loss, Insensible | 2008 |
4 other study(ies) available for fluocinonide and Atrophy
| Article | Year |
|---|---|
Cutaneous atrophy secondary to topical steroids.
Topics: Administration, Topical; Adult; Atrophy; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Skin | 1984 |
What's your assessment? Psoriasis with steroid atrophy.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Atrophy; Diagnosis, Differential; Fluocinonide; Glucocorticoids; Humans; Male; Psoriasis; Skin | 2001 |
Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Atrophy; Betamethasone; Body Weight; Dexamethasone; Disease Models, Animal; Flumethasone; Fluocinolone Acetonide; Fluocinonide; Flurandrenolone; Hydrocortisone; Male; Rats; Skin Diseases; Telangiectasis; Triamcinolone | 1976 |
Distal phalangeal atrophy secondary to topical steroid therapy.
Topics: Administration, Topical; Atrophy; Female; Fingers; Fluocinolone Acetonide; Fluocinonide; Humans; Middle Aged; Radiography | 1987 |